Pregled bibliografske jedinice broj: 329660
Eligibility of patients with acute myocardial infarction for thrombolytic therapy: Retrospective cohort study
Eligibility of patients with acute myocardial infarction for thrombolytic therapy: Retrospective cohort study // Croatian medical journal, 41 (2000), 4; 401-405 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 329660 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Eligibility of patients with acute myocardial infarction for thrombolytic therapy: Retrospective cohort study
Autori
Zaputović, Luka ; Mavrić, Žarko ; Mlinarić, Boris ; Kupanovac, Željko ; Matana, Ante ; Marinović, Đuro
Izvornik
Croatian medical journal (0353-9504) 41
(2000), 4;
401-405
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Age factors. Coronary care units. Eligibility determination. Myocardial infarction. Myocardial reperfusion. Patient selection. Streptokinase. Time factors. Thrombolytic therapy
Sažetak
Aim. To investigate the eligibility of patients with acute myocardial infarction (AMI) for thrombolytic therapy (TT) and evaluate the results of treatment. Methods. Retrospective analysis included 366 patients with AMI, mean age 66+/-11 years, treated in 1999. We analyzed age, gender, previous infarction, previous TT, present TT with streptokinase and its effects on the course and outcome, pain-to-door time, and door-to-needle time. Reperfusion and reocclusion were evaluated non-invasively according to the occurrence of the reperfusion and reocclusion syndrome. Results. One hundred patients (27%) underwent TT. It was less frequently applied in older patients, women, and patients with previous myocardial infarction. Reperfusion was achieved in 66 (66%) patients and reocclusion occurred in 9 (14%). Final outcome was successful in 57 (57%) patients. The TT group had more frequent arrhythmias (67% vs. 41%, p<0.001) and less frequent heart failure (20% vs. 39%, p<0.001) than the patients without TT. The mortality after TT was significantly lower (7% vs. 17%, p=0.015), without fatal outcome in patients with finally successful TT. Reasons against TT application were late arrival to hospital (51%) and contraindications for TT (34%). In patients without TT, the median pain-to-door time and door-to-needle time were significantly longer than in the TT group (7 vs. 2.5 hours and 55 vs. 20 min, respectively ; p<0.001). Conclusion Older age, female gender, previous myocardial infarction, and late arrival to the CCU negatively influence the use of TT in AMI. TT should be improved by shortening pain-to-door time, broadening indications, and limiting contraindications
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI
Uključenost u ostale bibliografske baze podataka::
- BIOSIS Previews (Biological Abstracts)
- MEDLINE
- ISI Alerting Service
- Science Citation Index®
- - Expanded (SciSearch®
- )
- Scopus